ClinVar Miner

Submissions for variant NM_002317.7(LOX):c.1190G>A (p.Arg397His)

gnomAD frequency: 0.00005  dbSNP: rs749796906
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001984615 SCV002214007 likely pathogenic not provided 2024-12-16 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 397 of the LOX protein (p.Arg397His). This variant is present in population databases (rs749796906, gnomAD 0.007%). This missense change has been observed in individuals with thoracic aortic aneurysm and/or dissection (internal data). ClinVar contains an entry for this variant (Variation ID: 1434346). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt LOX protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Ambry Genetics RCV002334927 SCV002644557 uncertain significance Cardiovascular phenotype 2022-02-28 criteria provided, single submitter clinical testing The p.R397H variant (also known as c.1190G>A), located in coding exon 6 of the LOX gene, results from a G to A substitution at nucleotide position 1190. The arginine at codon 397 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV003130621 SCV003817022 uncertain significance Aortic aneurysm, familial thoracic 10 2019-10-03 criteria provided, single submitter clinical testing
GeneDx RCV001984615 SCV003837419 uncertain significance not provided 2024-06-07 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.